For: | He XT, Cao XF, Ji L, Zhu B, Lv J, Wang DD, Lu PH, Cui HG. Association between Bmi1 and clinicopathological status of esophageal squamous cell carcinoma. World J Gastroenterol 2009; 15(19): 2389-2394 [PMID: 19452584 DOI: 10.3748/wjg.15.2389] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i19/2389.htm |
Number | Citing Articles |
1 |
Kriti Bahl, Anoop Saraya, Rinu Sharma. Increased Levels of Circulating and Tissue mRNAs of Oct-4, Sox-2, Bmi-1 and Nanog is ESCC Patients: Potential Tool for Minimally Invasive Cancer Diagnosis. Biomarker Insights 2012; 7: BMI.S8452 doi: 10.4137/BMI.S8452
|
2 |
Anne Laugesen, Kristian Helin. Chromatin Repressive Complexes in Stem Cells, Development, and Cancer. Cell Stem Cell 2014; 14(6): 735 doi: 10.1016/j.stem.2014.05.006
|
3 |
Aaron R. Huber, Dongfeng Tan, Jun Sun, David Dean, Tongtong Wu, Zhongren Zhou. High expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0310-6
|
4 |
Wan-li Liu, Xian-zhi Guo, Lan-jun Zhang, Jun-ye Wang, Ge Zhang, Su Guan, Yu-min Chen, Qing-li Kong, Li-hua Xu, Man-zhi Li, Li-bing Song, Mu-sheng Zeng. Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-467
|
5 |
Yingjie Shao, Yiting Geng, Wendong Gu, Zhonghua Ning, Jingting Jiang, Honglei Pei. Prognostic role of high Bmi-1 expression in Asian and Caucasian patients with solid tumors: A meta-analysis. Biomedicine & Pharmacotherapy 2014; 68(8): 969 doi: 10.1016/j.biopha.2014.10.017
|
6 |
Michael D. Amatangelo, Mark E. Stearns. Signaling Pathways and Molecular Mediators in Metastasis. 2011; : 13 doi: 10.1007/978-94-007-2558-4_2
|
7 |
Alea A. Mills. Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins. Nature Reviews Cancer 2010; 10(10): 669 doi: 10.1038/nrc2931
|
8 |
Huaijun Ji, Ming Cao, Kunlun Ren, Ningbo Sun, Wei Wang, Qiang Zhu, Qi Zang, Zhongmin Jiang. Expression and Clinicopathological Significance of Mel-18 and Bmi-1 in Esophageal Squamous Cell Carcinoma. Technology in Cancer Research & Treatment 2017; 16(6): 828 doi: 10.1177/1533034617705055
|
9 |
Morten Frier Gjerstorff, Mette Marie Relster, Katrine Buch Viden Greve, Jesper Bonnet Moeller, Daniel Elias, Jonas Nørrelund Lindgreen, Steffen Schmidt, Jan Mollenhauer, Bjørn Voldborg, Christina Bøg Pedersen, Nadine Heidi Brückmann, Niels Erik Møllegaard, Henrik Jørn Ditzel. SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repression. Nucleic Acids Research 2014; 42(18): 11433 doi: 10.1093/nar/gku852
|
10 |
H Richly, L Aloia, L Di Croce. Roles of the Polycomb group proteins in stem cells and cancer. Cell Death & Disease 2011; 2(9): e204 doi: 10.1038/cddis.2011.84
|
11 |
Eugenia Allegra, Serena Trapasso, Davide Pisani, Lidia Puzzo. The Role of BMI1 as a Biomarker of Cancer Stem Cells in Head and Neck Cancer: A Review. Oncology 2014; 86(4): 199 doi: 10.1159/000358598
|
12 |
KINUE KURIHARA, TOMOHIDE ISOBE, GOU YAMAMOTO, YOICHI TANAKA, AKIRA KATAKURA, TETSUHIKO TACHIKAWA. Expression of BMI1 and ZEB1 in epithelial-mesenchymal transition of tongue squamous cell carcinoma. Oncology Reports 2015; 34(2): 771 doi: 10.3892/or.2015.4032
|
13 |
Homa Fatma, Mohd Sadik Akhtar, Shahid Ali, Mehtab Ahmad, Hifzur R. Siddique. BMI-1 expression as a marker for gallbladder cancer progression. Journal of Medicine, Surgery, and Public Health 2023; 1: 100002 doi: 10.1016/j.glmedi.2023.100002
|
14 |
Chung‐Yin Wu, Jung‐Jyh Hung, Kou‐Juey Wu. Linkage between Twist1 and Bmi1: Molecular mechanism of cancer metastasis/stemness and clinical implications. Clinical and Experimental Pharmacology and Physiology 2012; 39(8): 668 doi: 10.1111/j.1440-1681.2011.05594.x
|
15 |
Bonnie Choy, Santhoshi Bandla, Yinglin Xia, Dongfeng Tan, Arjun Pennathur, James D Luketich, Tony E Godfrey, Jeffrey H Peters, Jun Sun, Zhongren Zhou. Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-146
|
16 |
Mohammad Mahdi Forghanifard, Sima Ardalan Khales, Afsaneh Javdani-Mallak, Abolfazl Rad, Moein Farshchian, Mohammad Reza Abbaszadegan. Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma. Medical Oncology 2014; 31(4) doi: 10.1007/s12032-014-0922-7
|
17 |
Gerhard F. Huber, Andrea Albinger‐Hegyi, Alex Soltermann, Matthias Roessle, Nicole Graf, Stephan K. Haerle, David Holzmann, Holger Moch, Ivan Hegyi. Expression patterns of Bmi‐1 and p16 significantly correlate with overall, disease‐specific, and recurrence‐free survival in oropharyngeal squamous cell carcinoma. Cancer 2011; 117(20): 4659 doi: 10.1002/cncr.26100
|
18 |
Cheng-Cheng Hwang, Shin Nieh, Chien-Hong Lai, Chien-Sheng Tsai, Liang-Che Chang, Chung-Ching Hua, Wen-Ying Chi, Hui-Ping Chien, Chih-Wei Wang, Siu-Cheung Chan, Tsan-Yu Hsieh, Jim-Ray Chen, Anthony WI. Lo. A Retrospective Review of the Prognostic Value of ALDH-1, Bmi-1 and Nanog Stem Cell Markers in Esophageal Squamous Cell Carcinoma. PLoS ONE 2014; 9(8): e105676 doi: 10.1371/journal.pone.0105676
|
19 |
Chenghui Zhou, Ningbo Fan, Fanyu Liu, Nan Fang, Patrick S. Plum, René Thieme, Ines Gockel, Sascha Gromnitza, Axel M. Hillmer, Seung-Hun Chon, Hans A. Schlösser, Christiane J. Bruns, Yue Zhao. Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer. Cells 2020; 9(6): 1481 doi: 10.3390/cells9061481
|
20 |
Qian Zhao, Xin Zhu, Jin-ming Ke, Xiao-yu Su, Jing Yi, De-long Wu, Jiang Lin, Zhao-qun Deng. Circular RNA BMI1 Serves as a Potential Target for Diagnosis and Treatment in Esophageal Cancer. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/15330338211033075
|
21 |
Fatemeh B. Rassouli, Maryam M. Matin, Morvarid Saeinasab. Cancer stem cells in human digestive tract malignancies. Tumor Biology 2016; 37(1): 7 doi: 10.1007/s13277-015-4155-y
|
22 |
Jihong Liu, Kai Liu, Xianli Jiang, Xueli Wang, Yunzhao Chen, Xiaobin Cui, Lijuan Pang, Shugang Li, Chunxia Liu, Hong Zou, Lan Yang, Jin Zhao, Yan Qi, Jian Ming Hu, Feng Li. Clinicopathological Significance of Bmi-1 Overexpression in Esophageal Cancer: a Meta-Analysis. Biomarkers in Medicine 2018; 12(1): 71 doi: 10.2217/bmm-2017-0092
|
23 |
David S. Schrump. Targeting epigenetic mediators of gene expression in thoracic malignancies. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2012; 1819(7): 836 doi: 10.1016/j.bbagrm.2012.03.009
|
24 |
Saffiyeh Saboor-Maleki, Fatemeh B. Rassouli, Maryam M. Matin, Mehrdad Iranshahi. Auraptene Attenuates Malignant Properties of Esophageal Stem-Like Cancer Cells. Technology in Cancer Research & Treatment 2017; 16(4): 519 doi: 10.1177/1533034616650119
|
25 |
Kai Jiao, Weijiao Jiang, Chunyang Zhao, Dewang Su, Haomin Zhang. Bmi-1 in gallbladder carcinoma: Clinicopathology and mechanism of regulation of human gallbladder carcinoma proliferation . Oncology Letters 2019; doi: 10.3892/ol.2019.10408
|